Hyperkalemia Completed Phase 2 Trials for Patiromer (DB09263)

Also known as: Hyperkalemia (HK) / Hyperkalaemia / Hyperpotassaemia / Hyperpotassemia / Potassium overload / Potassium [K] excess

IndicationStatusPhase
DBCOND0003949 (Hyperkalemia)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03799926Exploratory Study of ZG-801 for the Treatment of HyperkalemiaTreatment
NCT03071263Spironolactone With Patiromer in the Treatment of Resistant Hypertension in Chronic Kidney DiseaseTreatment
NCT01371747Patiromer in the Treatment of Hyperkalemia in Patients With Hypertension and Diabetic Nephropathy (AMETHYST-DN)Treatment
NCT00868439Evaluation of Patiromer in Heart Failure PatientsPrevention